James T. Borello
VRTX icon

James T. Borello’s Vertex Pharmaceuticals VRTX Stock Holding History

James T. Borello’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$50.2K Hold
96
– – 0.01% 246
2026
Q2 		$47.7K Buy
96
+11
+13% +$4.88K 0.01% 243
2026
Q1 		$38K Buy
85
+35
+70% +$16.3K 0.01% 255
2025
Q4 		$22.7K Buy
50
+20
+67% +$8.62K 0.01% 263
2025
Q3 		$11.7K Buy
+30
New +$12.5K ﹤0.01% 290

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

James T. Borello's VRTX Position: Q3 2026 in Review

James T. Borello held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 96 shares worth $50.2K. The position accounts for 0.01% of the portfolio, ranked #246.

James T. Borello first reported a position in VRTX in Q3 2025 and has held it in 5 quarters since. 759 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • James T. Borello held 96 shares of Vertex Pharmaceuticals worth $50.2K as of Q3 2026.
  • James T. Borello left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.01% of James T. Borello's portfolio in Q3 2026, its #246 holding.
  • James T. Borello first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 759 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.